Skip to content
Subscriber Only

Takeda Denies Actos Bladder-Cancer Link at First Trial

Takeda Pharmaceutical Co., Asia’s biggest drugmaker, denied its Actos drug caused a California man’s bladder cancer in the first of more than 3,000 lawsuits over the diabetes medication to go to trial.

Plaintiff Jack Cooper developed bladder cancer, the fifth-most common form of cancer, as a result of factors other taking Actos, Sara Gourley, a Takeda lawyer, told a state court jury in Los Angeles today. Cooper, 79, is diabetic and a former smoker, she said.